Christopher R. Fenimore - SEC Form 4 Insider Trading Activity
SVP Finance & CFO
Summary
Updated Aug 16, 2026
Christopher R. Fenimore is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Christopher R. Fenimore is SVP Finance & CFO at REGENERON PHARMACEUTICALS, INC. (REGN). Fenimore has reported 2 insider filings with the SEC since 2024. The most recent filing was in December 2024.
- Role
- SVP Finance & CFO
Board memberships
- REGENERON PHARMACEUTICALS, INC.
Trading Pattern
InsiderAlpha's records for Christopher R. Fenimore go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Christopher R. Fenimore has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- SVP Finance & CFO at REGENERON PHARMACEUTICALS, INC. (REGN) - 2 filings, 2024
Recent Transactions
3Most Active Insiders Right Now
Christopher R. Fenimore has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
- Magnetar Financial LLC - $6.62B of CRWV open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
- SGF FANG Holdings, LP - $2.04B of FANG open-market activity in the last 90 days
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
- BCP 8 Holdings Mozart Manager L.L.C. - $1.22B of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher R. Fenimore?
Christopher R. Fenimore is SVP Finance & CFO at REGENERON PHARMACEUTICALS, INC. (REGN). Fenimore has reported 2 insider filings with the SEC since 2024. The most recent filing was in December 2024.…
Where can I see all of Christopher R. Fenimore's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Christopher R. Fenimore files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required